Cancer Treatment Centers of America
(800) 615-3055

Have questions? Call (800) 615-3055 to speak to a cancer information specialist.

Cancer Treatment Centers of America at Midwestern Regional Medical Center Launches Head and Neck Cancer Program

Acclaimed surgical oncologist Carol Bier-Laning, MD, FASC, joins CTCA to lead comprehensive program for the treatment of head and neck cancer to offer surgical options for ear, nose and throat cancers

CHICAGO, March 5, 2014 /PRNewswire-USNewswire/ -- Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center (Midwestern) has launched a comprehensive head and neck cancer program to serve patients with cancers of the oral cavity, throat, larynx, nasal cavity, salivary gland, thyroid, and skin of the head and neck.  Esteemed surgical oncologist Carol Bier-Laning, MD, FASC, has joined CTCA to lead the program, which will offer innovative new treatment options and integrative care to patients.

"We are excited to launch a formal head and neck cancer program and are pleased to welcome Dr. Bier-Laning to CTCA," said Scott Jones, CEO and president of CTCA at Midwestern. "Dr. Bier-Laning is an outstanding surgeon with tremendous experience treating head and neck cancer.  We are excited to have her at the helm as we expand our head and neck cancer care and bring innovative new treatment options to our patients."

The head and neck cancer program at CTCA provides patients with access to all aspects of their care under one roof.  Experts use state-of-the-art diagnostic tools, including advanced imaging and laboratory tests, to evaluate head and neck cancer and work as a multidisciplinary team to develop a comprehensive treatment plan.  Each individualized plan includes advanced medical treatments and technologies, combined with integrative oncology services to help reduce side effects and keep patients physically and emotionally strong. 

"CTCA puts patients in control and offers a truly comprehensive and supportive environment for care.  I am honored to join the hospital and to contribute to the surgical oncology team so we may work together to expand treatment options for patients," said Bier-Laning.

Board certified in otolaryngology, Bier-Laning holds more than 16 years of experience in her field. In addition to seeing patients at CTCA, she serves Loyola University Medical Center as an Associate Professor and sees patients there as well as at Edward Hines, Jr. VA Hospital in Chicago. Bier-Laning completed her fellowship in head and neck oncology at The Ohio State University and performed her residency in otolaryngology at the University of Minnesota. She is a graduate of the University of Colorado Medical School.  Bier-Laning holds professional membership with several organizations including the American Academy of Otolaryngology-Head and Neck Surgery, American Board of Otolaryngology, American Head and Neck Society, American College of Surgeons and Chicago Laryngological and Otological Society. 

About Cancer Treatment Centers of America at Midwestern Regional Medical Center

Cancer Treatment Centers of America® (CTCA) at Midwestern Regional Medical Center is a 73 bed specialty hospital dedicated to treating patients battling complex cancer.  CTCA® at Midwestern is nationally recognized for providing innovative and individualized cancer care and has been designated by the American Nurses Credentialing Center (ANCC) a Magnet Recognized® program, ranking the hospital as one of the top seven percent in the nation for nursing excellence.  CTCA at Midwestern has been designated by the National Quality Measures for Breast Centers Program (NQMBC®) as a Certified Quality Breast Center of Excellence™, ranking the hospital among the top centers in the country for quality breast cancer care.  CTCA at Midwestern is the only Certified Breast Center of Excellence in Illinois, and one of only 41 nationally.  As a member of the National Marrow Donor Program (NMDP) the hospital also offers a Stem Cell Transplant and Cell Therapy program that provides a full spectrum of transplantation services and advanced treatment options for hematologic cancers. CTCA at Midwestern is proud to use the latest technology to offer advanced treatment for cancer and is currently one of only a few hospitals in the nation to combine recent advances in brain mapping and navigation to perform minimally invasive brain surgery on hard to reach brain tumors.

About Cancer Treatment Centers of America®
Cancer Treatment Centers of America Global, Inc. (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-informed supportive therapies designed to help patients physically and emotionally by enhancing their quality of life while managing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Reflecting our patient-centered approach to cancer care, our patient satisfaction scores consistently rank among the highest in the country for cancer care providers, and CTCA is also rated one of the most admired hospital systems in the country in national consumer surveys. For more information, visit, and